186 related articles for article (PubMed ID: 8568273)
1. Rat MHC-linked peptide transporter alleles strongly influence peptide binding by HLA-B27 but not B27-associated inflammatory disease.
Simmons WA; Leong LY; Satumtira N; Butcher GW; Howard JC; Richardson JA; Slaughter CA; Hammer RE; Taurog JD
J Immunol; 1996 Feb; 156(4):1661-7. PubMed ID: 8568273
[TBL] [Abstract][Full Text] [Related]
2. A new MHC locus that influences class I peptide presentation.
Simmons WA; Roopenian DC; Summerfield SG; Jones RC; Galocha B; Christianson GJ; Maika SD; Zhou M; Gaskell SJ; Bordoli RS; Ploegh HL; Slaughter CA; Lindahl KF; Hammer RE; Taurog JD
Immunity; 1997 Nov; 7(5):641-51. PubMed ID: 9390688
[TBL] [Abstract][Full Text] [Related]
3. Sharing of an HLA-B27-restricted H-Y antigen between rat and mouse.
Simmons WA; Taurog JD; Hammer RE; Breban M
Immunogenetics; 1993; 38(5):351-8. PubMed ID: 8344721
[TBL] [Abstract][Full Text] [Related]
4. Specificities of human TAP alleles for HLA-B27 binding peptides.
Kuipers JG; Raybourne RB; Williams KM; Zeidler H; Yu DT
Arthritis Rheum; 1996 Nov; 39(11):1892-5. PubMed ID: 8912512
[TBL] [Abstract][Full Text] [Related]
5. Novel HY peptide antigens presented by HLA-B27.
Simmons WA; Summerfield SG; Roopenian DC; Slaughter CA; Zuberi AR; Gaskell SJ; Bordoli RS; Hoyes J; Moomaw CR; Colbert RA; Leong LY; Butcher GW; Hammer RE; Taurog JD
J Immunol; 1997 Sep; 159(6):2750-9. PubMed ID: 9300696
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous inflammatory disease in HLA-B27 transgenic mice does not require transporter of antigenic peptides.
Khare SD; Lee S; Bull MJ; Hanson J; Luthra HS; David CS
Clin Immunol; 2001 Mar; 98(3):364-9. PubMed ID: 11237560
[TBL] [Abstract][Full Text] [Related]
7. The effect of an anti-HLA-B27 immune response on CTL recognition of Chlamydia.
Popov I; Dela Cruz CS; Barber BH; Chiu B; Inman RD
J Immunol; 2001 Sep; 167(6):3375-82. PubMed ID: 11544328
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic T-cell-mediated response against Yersinia pseudotuberculosis in HLA-B27 transgenic rat.
Falgarone G; Blanchard HS; Riot B; Simonet M; Breban M
Infect Immun; 1999 Aug; 67(8):3773-9. PubMed ID: 10417137
[TBL] [Abstract][Full Text] [Related]
9. The specificity of peptides bound to human histocompatibility leukocyte antigen (HLA)-B27 influences the prevalence of arthritis in HLA-B27 transgenic rats.
Zhou M; Sayad A; Simmons WA; Jones RC; Maika SD; Satumtira N; Dorris ML; Gaskell SJ; Bordoli RS; Sartor RB; Slaughter CA; Richardson JA; Hammer RE; Taurog JD
J Exp Med; 1998 Sep; 188(5):877-86. PubMed ID: 9730889
[TBL] [Abstract][Full Text] [Related]
10. Recognition of chlamydial antigen by HLA-B27-restricted cytotoxic T cells in HLA-B*2705 transgenic CBA (H-2k) mice.
Kuon W; Lauster R; Böttcher U; Koroknay A; Ulbrecht M; Hartmann M; Grolms M; Ugrinovic S; Braun J; Weiss EH; Sieper J
Arthritis Rheum; 1997 May; 40(5):945-54. PubMed ID: 9153558
[TBL] [Abstract][Full Text] [Related]
11. HLA-B27-restricted antigen presentation in the absence of tapasin reveals polymorphism in mechanisms of HLA class I peptide loading.
Peh CA; Burrows SR; Barnden M; Khanna R; Cresswell P; Moss DJ; McCluskey J
Immunity; 1998 May; 8(5):531-42. PubMed ID: 9620674
[TBL] [Abstract][Full Text] [Related]
12. Requirements for HLA-B*2705-binding peptides with special regard to the transporter associated with antigen processing (TAP).
Kuipers JG; Raybourne R; Williams KM; Zeidler H; Yu DT
Clin Exp Rheumatol; 1996; 14(5):523-9. PubMed ID: 8913654
[TBL] [Abstract][Full Text] [Related]
13. Defective costimulatory function is a striking feature of antigen-presenting cells in an HLA-B27-transgenic rat model of spondylarthropathy.
Hacquard-Bouder C; Falgarone G; Bosquet A; Smaoui F; Monnet D; Ittah M; Breban M
Arthritis Rheum; 2004 May; 50(5):1624-35. PubMed ID: 15146433
[TBL] [Abstract][Full Text] [Related]
14. NK cells from human MHC class I (HLA-B) transgenic mice do not mediate hybrid resistance killing against parental nontransgenic cells.
Kung SK; Su RC; Graham JJ; Chamberlain JW; Miller RG
J Immunol; 1998 Jan; 160(2):674-80. PubMed ID: 9551902
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression.
Taurog JD; Maika SD; Simmons WA; Breban M; Hammer RE
J Immunol; 1993 May; 150(9):4168-78. PubMed ID: 8473755
[TBL] [Abstract][Full Text] [Related]
16. The distribution of Tap2 alleles among laboratory rat RT1 haplotypes.
Joly E; Deverson EV; Coadwell JW; Günther E; Howard JC; Butcher GW
Immunogenetics; 1994; 40(1):45-53. PubMed ID: 8206525
[TBL] [Abstract][Full Text] [Related]
17. Specificity and frequency of primary anti-HLA cytotoxic T lymphocytes in normal and HLA-B27.2-, HLA-B27.5-, and HLA-Cw3-transgenic mice. A transgenic model for MHC xenoantigen recognition.
Kievits F; Boerenkamp WJ; Lokhorst W; Ivanyi P
J Immunol; 1990 Jun; 144(12):4513-9. PubMed ID: 2351823
[TBL] [Abstract][Full Text] [Related]
18. [Study on the association of transporter associated with antigen processing gene with ankylosing spondylitis and HLA-B27 in Han nationality].
Wang B; Su H; Gao P; Tao L; Li X; Yie D
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Jun; 18(3):209-12. PubMed ID: 11402452
[TBL] [Abstract][Full Text] [Related]
19. Unusual topology of an HLA-B27 allospecific T cell epitope lacking peptide specificity.
Villadangos JA; Galocha B; López de Castro JA
J Immunol; 1994 Mar; 152(5):2317-23. PubMed ID: 7510742
[TBL] [Abstract][Full Text] [Related]
20. Changes in the repertoire of peptides bound to HLA-B27 subtypes and to site-specific mutants inside and outside pocket B.
Rojo S; García F; Villadangos JA; López de Castro JA
J Exp Med; 1993 Mar; 177(3):613-20. PubMed ID: 8436905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
